Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms
15 sept. 2021 09h00 HE
|
Owkin
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces an agreement with Actelion...
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
14 sept. 2021 09h01 HE
|
Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
Medical Biomimetics Market Revenue 2021: Top 4 Trends Driving the Industry Expansion Through 2027; Global Market Insights Inc.
18 août 2021 06h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The medical biomimetics market size is anticipated to record a valuation of USD 53 billion by 2027, according to the most recent study by...
CVRx Reports Second Quarter 2021 Financial and Operating Results
04 août 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference
29 juil. 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
28 juil. 2021 08h00 HE
|
ARCA biopharma, Inc.
Analysis in full patient cohort shows Gencaro effect compared to standard of careIn the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with...
CVRx to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call
21 juil. 2021 17h28 HE
|
CVRx, Inc.
MINNEAPOLIS, July 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of Directors
12 juil. 2021 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, July 12, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
Global Fluoroscopy Equipment Market To Garner $6.50 Billion By 2028: Allied Market Research
24 juin 2021 09h30 HE
|
Allied Market Research
Portland, OR, June 24, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Fluoroscopy Equipment Market generated $4.07 billion in 2020, and is estimated...
InCarda Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for InRhythm™ for Treatment of Atrial Fibrillation
23 juin 2021 08h05 HE
|
InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial in Atrial Fibrillation Acceptable to Support Filing of New Drug Application Company on Track to Initiate Phase 3 RESTORE1 Study in Q3 2021 with Data Expected 2H 2022 ...